Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details Narrative)

Stockholders' Deficit (Details Narrative) - USD ($)									1 Months Ended	3 Months Ended		6 Months Ended
Stockholders' Deficit (Details Narrative) - USD ($)	Jun. 30, 2020	Jun. 16, 2020	May 27, 2020	May 05, 2020	May 04, 2020	Dec. 23, 2019	May 12, 2019	Mar. 27, 2019	Sep. 30, 2017	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Jun. 09, 2020	Dec. 31, 2019
Common stock shares authorized	10,000,000,000									10,000,000,000		10,000,000,000			10,000,000,000
Common stock par value	$ 0.0001									$ 0.0001		$ 0.0001			$ 0.0001
Preferred stock shares authorized	5,000,000									5,000,000		5,000,000
Preferred stock par value	$ 0.01									$ 0.01		$ 0.01
Number of common stock issued, value										$ 2,500
Deemed dividend												$ 123,900,000
Common stock shares issued	989,894									989,894		989,894			964,894
Common stock shares outstanding	989,894									989,894		989,894			964,894
Stock-based compensation													$ 17,300
Interest expenses											$ 9,500,000		5,400,000
2007 Equity Plan [Member]
Stock-based compensation													17,300
Weighted average period												5 years 9 months 29 days
Intrinsic value of options exercisable	$ 0									$ 0		$ 0
Alcimede LLC [Member] \| Mr. Lagan [Member]
Voting rights percentage			Mr. Lagan and Alcimede LLC, the holders of 50.25% of the total voting power of the Company's voting securities.
Reverse stock split, description			1-for-100 to 1-for-10,000
Exchange Agreement [Member]
Number of shares issued upon conversion, value					$ 250,000
Warrants [Member]
Warrants outstanding	63,500,000									63,500,000		63,500,000
Warrant expiration date							Mar. 31, 2022
Fair value of warrants							$ 5,400,000	$ 4,100,000
Interest expenses										$ 5,400,000			$ 9,500,000
Series H Preferred Stock [Member]
Preferred stock shares authorized	14,202									14,202		14,202			14,202
Preferred stock par value	$ 0.01									$ 0.01		$ 0.01			$ 0.01
Preferred stock shares outstanding	10									10		10			10
Preferred stock, stated value	$ 1,000									$ 1,000		$ 1,000
Series F Convertible Preferred Stock [Member]
Preferred stock shares outstanding	1,750,000									1,750,000		1,750,000
Series F Convertible Preferred Stock [Member] \| Genomas, Inc [Member]
Number of common shares issued									1,750,000
Number of common stock issued, value									$ 174,097
Series L Convertible Preferred Stock [Member]
Preferred stock shares outstanding	250,000									250,000		250,000
Series M Preferred Stock [Member]
Preferred stock shares authorized	30,000									30,000		30,000		30,000	30,000
Preferred stock par value	$ 0.01									$ 0.01		$ 0.01		$ 1,000	$ 0.01
Preferred stock shares outstanding	22,000									22,000		22,000			0
Debt and accrued interest												$ 22,000,000
Debt description		Regardless of the number of shares of Series M Preferred Stock outstanding and so long as at least one share of Series M Preferred Stock is outstanding, the outstanding shares of Series M Preferred Stock shall have the number of votes, in the aggregate, equal to 51% of all votes entitled to be voted at any meeting of stockholders or action by written consent. Each outstanding share of the Series M Preferred Stock shall represent its proportionate share of the 51% allocated to the outstanding shares of Series M Preferred Stock in the aggregate.
Conversion rate		90.00%
Dividend rate		10.00%
Series M Preferred Stock [Member] \| Mr. Diamantis [Member]
Preferred stock, stated value	$ 0.01									$ 0.01		$ 0.01
Extinguishment of debt	$ 18,800,000
Exchange of shares	22,000
Deemed dividend										$ 3,200,000		$ 3,200,000
Debt and accrued interest												$ 18,800,000
Series H Preferred Stock [Member]
Weighted average common stock price percentage												85.00%
Series K Preferred Stock [Member]
Preferred stock shares authorized	250,000									250,000		250,000			250,000
Preferred stock par value	$ 0.01									$ 0.01		$ 0.01			$ 0.01
Preferred stock shares outstanding	0									0		0			250,000
Series K Preferred Stock [Member] \| Exchange Agreement [Member] \| Alcimede LLC [Member]
Number of shares issued upon conversion, value				$ 250,000		$ 250,000
Cumulative dividends percentage						8.00%
Series J Preferred Stock [Member] \| Exchange Agreement [Member] \| Alcimede LLC [Member]
Number of shares issued upon conversion, value						$ 250,000
Series L Preferred Stock [Member]
Preferred stock shares authorized	250,000									250,000		250,000			250,000
Preferred stock par value	$ 0.01									$ 0.01		$ 0.01			$ 0.01
Preferred stock shares outstanding	250,000									250,000		250,000			0
Series L Preferred Stock [Member] \| Exchange Agreement [Member] \| Alcimede LLC [Member]
Number of shares issued upon conversion, value				$ 250,000
Series I-2 Preferred Stock [Member]
Preferred stock shares outstanding	1,521.65									1,521.65		1,521.65
Number of common shares issued												25,000
Number of shares converted												21.25	769.2276